Trotz zunehmender Beweise dafür, dass GLP-1-Medikamente die Gesundheit verbessern und ihren Preis wert sind, schränken viele amerikanische Versicherungspläne den Versicherungsschutz immer noch ein. „Kostengünstig“ bedeutet für Versicherungsunternehmen nicht unbedingt „kostensparend“.

**Ole Miss researchers study barriers to GLP-1 insurance coverage**

*Insurance companies often do not cover GLP-1 medications for weight loss, despite evidence that the drugs work and are worth the cost. A University of Mississippi-led study found that insurers would have to offer more services than just the medication to produce long-term cost savings.*

***For patients whose insurance won’t cover GLP-1 medications, lower-cost compounded versions can seem like an attractive alternative, but the researchers urge caution.***

Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why, and where that leaves patients.
A recent report from the [Institute for Clinical and Economic Review,](https://tracking.us.nylas.com/l/4dcefcc4fbc14fa2ad54329809479517/1/8928b4a2a124fbefdcadf1cda19f83d9cf305f58c3fed8e2a9c2b9eb3960d789?cache_buster=1784561007) an independent nonprofit that evaluates the value of medical treatments, found that GLP-1s such as Ozempic, Wegovy and Zepbound are cost-effective, meaning the medication’s health benefits justify their price.

In a study published in the [Journal of Managed Care and Specialty Pharmacy](https://tracking.us.nylas.com/l/4dcefcc4fbc14fa2ad54329809479517/2/cb5db960f1034fa3d0b6b26ec1b94ead2a398ce38c6d0b19b609d39d828ff103?cache_buster=1784561007), Sujith Ramachandran, associate professor of pharmacy administration, said that “cost-effective” does not necessarily mean “cost-saving” for insurance companies.

https://www.jmcp.org/doi/10.18553/jmcp.2026.32.6.753

Problem seems to be that a convergence of financial and policy factors are forcing governments to be penny-wise, pound-foolish, and the real potential savings are going to take a couple decades to realize.

There is no way these shots are more expensive than the plethora of issues that come from being obese. Diabetes, apnea, mental health, and many others. Will they work on their own? Almost certainly not, but combining this with better habits and education would be able to save lives.

I would not be surprised if the food manufacturers are paying the insurance companies not to cover these GLP-1 medications. These drugs remove the desire to eat, to binge eat, to stress eat, to eat out of boredom, which would eradicate the billions of dollars these food manufacturers put into R&D and developing overly processed food that trick the bodies normal triggers so their customers get not only get addicted, they eat more of the product that are high in calories, but provide very little nutrition and are not very filling.

I’m really struggling with this personally.

My doctor straight up told me, if my A1C rose enough, then I could get the medication. So essentially I have to get diabetes instead of preventing it. Otherwise, the GLP is like 600 a month.

It’s infuriating. I really, really need it, I need to lose a significant amount of weight because I live in constant pain due to an incurable hereditary disease, not to mention it could help me stop smoking too from what I read.

This stuff is a miracle drug but only wealthy people have access to it it seems.

I once saw a research paper that found that smokers were actually cheaper overall on healthcare costs because they tended to die earlier. Perhaps it’s the same for obese people. They die earlier and don’t need as much healthcare in old age? It’s probably more profitable for insurance companies if you die to your illness quite often.

Insurance companies are not in this business for your health. They’re in it to make lots and lots of money for themselves and their investors. Don’t be confused by the name of the business. “Health insurance” doesn’t mean “health benefits”.